19th January 2021

HHS Expands MAT Patient Access to Care, Cuts Prescribing Hurdles

The Department of Health & Human Services has issued guidance to do away with the so-called X-waiver, a move the agency said will increase the number of providers able to deliver medication-assisted treatment and therefore increase patient access to care. “The medical evidence is clear: access to medication-assisted treatment, including buprenorphine that can be prescribed in office-based settings, is the gold standard for treating individuals suffering from opioid use disorder,” Adm. Brett P. Giroir, MD, assistant secretary for health, said in a public statement.

Read More

For more information about Bridge Therapeutics please contact us today using the form below.